Correlation Between Manhattan Scients and VentriPoint Diagnostics
Can any of the company-specific risk be diversified away by investing in both Manhattan Scients and VentriPoint Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Manhattan Scients and VentriPoint Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Manhattan Scients and VentriPoint Diagnostics, you can compare the effects of market volatilities on Manhattan Scients and VentriPoint Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Manhattan Scients with a short position of VentriPoint Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Manhattan Scients and VentriPoint Diagnostics.
Diversification Opportunities for Manhattan Scients and VentriPoint Diagnostics
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Manhattan and VentriPoint is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Manhattan Scients and VentriPoint Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VentriPoint Diagnostics and Manhattan Scients is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Manhattan Scients are associated (or correlated) with VentriPoint Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VentriPoint Diagnostics has no effect on the direction of Manhattan Scients i.e., Manhattan Scients and VentriPoint Diagnostics go up and down completely randomly.
Pair Corralation between Manhattan Scients and VentriPoint Diagnostics
Given the investment horizon of 90 days Manhattan Scients is expected to generate 2.4 times more return on investment than VentriPoint Diagnostics. However, Manhattan Scients is 2.4 times more volatile than VentriPoint Diagnostics. It trades about 0.04 of its potential returns per unit of risk. VentriPoint Diagnostics is currently generating about 0.0 per unit of risk. If you would invest 0.52 in Manhattan Scients on November 5, 2024 and sell it today you would lose (0.51) from holding Manhattan Scients or give up 98.08% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Manhattan Scients vs. VentriPoint Diagnostics
Performance |
| Timeline |
| Manhattan Scients |
| VentriPoint Diagnostics |
Manhattan Scients and VentriPoint Diagnostics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Manhattan Scients and VentriPoint Diagnostics
The main advantage of trading using opposite Manhattan Scients and VentriPoint Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Manhattan Scients position performs unexpectedly, VentriPoint Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VentriPoint Diagnostics will offset losses from the drop in VentriPoint Diagnostics' long position.| Manhattan Scients vs. VentriPoint Diagnostics | Manhattan Scients vs. Cannabix Technologies | Manhattan Scients vs. Accelerate Diagnostics | Manhattan Scients vs. Venus Concept |
| VentriPoint Diagnostics vs. Rimrock Gold Corp | VentriPoint Diagnostics vs. V Group | VentriPoint Diagnostics vs. Protext Mobility | VentriPoint Diagnostics vs. SNM Gobal Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |